Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958).

Thill, Marc; Wimberger, Pauline; Grafe, Andrea; Klare, Peter; Luedtke-Heckenkamp, Kerstin; Reichert, Dietmar; Zaiss, Matthias; Ziegler-Löhr, Katja; Eckl, Tanja; Schneeweiss, Andreas

Thill, Marc; Wimberger, Pauline; Grafe, Andrea; Klare, Peter; Luedtke-Heckenkamp, Kerstin; Reichert, Dietmar; Zaiss, Matthias; Ziegler-Löhr, Katja; Eckl, Tanja; Schneeweiss, Andreas.

Afiliação

Thill M; Department of Gynecology and Gynecological Oncology, Agaplesion Markus Hospital, Frankfurt A. M, Germany. marc.thill@agaplesion.de.
Wimberger P; Department of Gynecology and Obstetrics, TU Dresden and National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
Grafe A; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Klare P; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Luedtke-Heckenkamp K; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Reichert D; Medical Center Nordhausen gGmbH, Nordhausen, Germany.
Zaiss M; Gynecological Out-Patient Clinic, Berlin, Germany.
Ziegler-Löhr K; Center for Oncology and Hematology, Niels-Stensen-Clinics, Franziskus-Hospital Harderberg, Georgsmarienhütte, Germany.
Eckl T; Center for Oncology, Westerstede, Germany.
Schneeweiss A; Practice for Interdisciplinary Oncology & Hematology, Freiburg, Germany.

Breast Cancer Res Treat ; 196(2): 311-321, 2022 Nov.

Article em En | MEDLINE | ID: mdl-36094611

Assuntos

Neoplasias da Mama; Segunda Neoplasia Primária; Humanos; Adulto; Pessoa de Meia-Idade; Idoso; Idoso de 80 Anos ou mais; Feminino; Trastuzumab/efeitos adversos; Neoplasias da Mama/patologia; Receptor ErbB-2; Docetaxel/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Recidiva Local de Neoplasia/patologia; Segunda Neoplasia Primária/etiologia

Palavras-chave

Cancer; Dual HER2 blockade; HER2-positive; Metastatic breast; Pertuzumab; Trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Segunda Neoplasia Primária Tipo de estudo: Etiology_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google